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Objective: To summarize literature on the responsiveness and reliability of MRI-based measures of knee
osteoarthritis (OA) structural change.
Methods: A literature search was conducted using articles published up to the time of the search, April
2009. 1338 abstracts obtained with this search were preliminarily screened for relevance and of these,
243 were selected for data extraction. For this analysis we extracted data on reliability and respon-
siveness for every reported synovial joint tissue as it relates to MRI measurement in knee OA. Reliability
was deﬁned by inter- and intra-reader intra-class correlation (ICC), or coefﬁcient of variation, or kappa
statistics. Responsiveness was deﬁned as standardized response mean (SRM) - ratio of mean of change
over time divided by standard deviation of change. Random-effects models were used to pool data from
multiple studies.
Results: The reliability analysis included data from 84 manuscripts. The inter-reader and intra-reader ICC
were excellent (range 0.8e0.94) and the inter-reader and intra-reader kappa values for quantitative and
semi-quantitative measures were all moderate to excellent (range 0.52e0.88). The lowest value
(kappa¼ 0.52) corresponded to semi-quantitative synovial scoring intra-reader reliability and the
highest value (ICC¼ 0.94) for semi-quantitative cartilage morphology.
The responsiveness analysis included data from 42 manuscripts. The pooled SRM for quantitative
measures of cartilage morphometry for the medial tibiofemoral joint was 0.86 (95% conﬁdence
intervals (CI) 1.26 to 0.46). The pooled SRM for the semi-quantitative measurement of cartilage
morphology for the medial tibiofemoral joint was 0.55 (95% CI 0.47e0.64). For the quantitative analysis,
SRMs are negative because the quantitative value, indicating a loss of cartilage, goes down. For the semi-
quantitative analysis, SRMs indicating a loss in cartilage are positive (increase in score).
Conclusion: MRI has evolved substantially over the last decade and its strengths include the ability to
visualize individual tissue pathologies, which can be measured reliably and with good responsiveness
using both quantitative and semi-quantitative techniques.
 2011 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
One proposed osteoarthritis (OA) treatment goal is modiﬁca-
tion of the underlying joint structure. Highly reproducible and
responsive measures of the rate of disease progression are
a prerequisite for assessing structural change in clinical trials.avid J. Hunter, Rheumatology
Clinical School, University of
Fax: 61-2-9906-1859.
Hunter).
s Research Society International. PConventional radiography (CR) has been the mainstay of assessing
structural change in OA clinical trials and is currently part of FDA
recommendations on how to conduct trials to assess structural
progression. The focus of such evaluations has been on the
radiographic joint space as a surrogate for hyaline cartilage
assessment.
There has been a growing awareness that symptomatic OA
represents a process involving all the tissues in the OA joint.
Structure modiﬁcation should therefore be considered in a broader
context than that of cartilage alone. Modern imaging, especially
magnetic resonance imaging (MRI), allows unparalleled direct
visualization of all the tissues involved in OA joint pathology,ublished by Elsevier Ltd. All rights reserved.
D.J. Hunter et al. / Osteoarthritis and Cartilage 19 (2011) 589e605590including cartilage, menisci, subchondral bone and soft tissue. MRI
is ideally suited for imaging arthritic joints as is it is free of ionizing
radiation, and its tomographic viewing perspective obviates
morphological distortion, magniﬁcation and superimposition.
More importantly, MRI has a rich image contrast variability
resulting in an ability to discriminate articular tissues and it
therefore holds great potential as a tool for whole-organ imaging of
the OA joint. The last 20 years has seen a rapid improvement in
imaging technology and in the last decade this has translated into
improved understanding of the importance of individual features,
their relation to clinical outcome and disease pathogenesis and
better data on the quantiﬁcation of these pathologies1,2. There is
a wealth of literature on the measurement properties of MRI in the
setting of OA including responsiveness and reliability. Prior to
considering the merits of MRI in the setting of potential disease
modifying trials and trial guidance it is important to review this
systematically.
The objective of this review was to summarize the literature on
the responsiveness and reliability of MRI-based measures of knee
OA structural change.
Material and methods
Systematic literature search details
An online literature search was conducted using the OVID
MEDLINE (1945e), EMBASE (1980e) and Cochrane databases
(1998e). The search was not limited by publication date and the
last search occurred in April 2009, with the search entries “MRI”,
and “osteoarthritis”, “osteoarthritides”, “osteoarthrosis”, “osteo-
arthroses”, “degenerative arthritis”, “degenerative arthritides”, or
“osteoarthritis deformans”. The abstracts of the 1330 citations
received with this search were then preliminarily screened for
relevance by two reviewers (KH and DJH). Although review arti-
cles were not included (see Inclusion/exclusion criteria), citations
found in any review articles which were not already included in
our preliminary search were screened for possible inclusion in this
study. This added seven more relevant studies to our search. One
further article was added, before publication, by one of the
authors of this meta-analysis bringing the preliminary total to
1338.1330 articles identified in 
OVID, PubMed and EMBASE 
1338 articles iden
243 articles s
84 articles reporting reliability 
results
Fig. 1. Flow chart of the screening process forInclusion/exclusion criteria
Only studies published in English were included. Studies pre-
senting non-original data were excluded, such as reviews, edito-
rials, opinion papers, case studies or letters to the editor. Studies
with questionable clinical relevance and those using non-human
subjects or specimens were excluded. Studies inwhich rheumatoid,
inﬂammatory, or other forms of arthritis were included in the OA
datasets were excluded, as well as general joint-pertinent MRI
studies not focused on OA. Studies with no extractable, numerical
data were excluded. Any duplicates which came up in the prelim-
inary search were excluded. Of the preliminary 1338 abstracts, 243
were selected for data extraction (Fig. 1).Data abstraction
We used a data abstraction tool constructed in EpiData (Entry
version 2.0 Odense, Denmark). Two reviewers (KH and LM) inde-
pendently abstracted the following data: (1) patient demographics;
(2) MRI make (vendor and ﬁeld strength), sequences and tech-
niques used (see further description below), tissue types viewed;
(3) study type and funding source; (4) details on rigor of study
design to construct the Downs methodological quality score (see
further description below)3; (5) MRI reliability/reproducibility
data; (6) MRI diagnostic measures and performance; (7) gold
standard measures against which the MRI measure was evaluated;
(8) treatment and MRI measures (when appropriate).
Multiple techniques have been used to measure structural
abnormality and change on MRI in OA. Broadly speaking these
methods are divided into quantitative and semi-quantitative
methods1. Quantitative measurements using computer-aided image
processing to assess whole joint quantiﬁcation (cartilage
morphometry, bone volume, bone marrow lesion volume, meniscal
position and volume, synovial volume, etc). The three-dimensional
(3D) coverage of an entire cartilaginous region by MRI allows for the
direct quantiﬁcation of volumetric structures. Compositional
measures of articular cartilage are also included within the quanti-
tative measures as the measurement provides for a quantitative
output. Thesemethods include T2mapping, dGEMRIC and T1rho and
are extensively reviewed elsewhere4,5.8 articles identified manually 
tified in total 
creened 
42 articles reporting
responsiveness results 
articles included in the systematic review.
Table I
Summary table of studies reporting data on reliability of MRI in knee OA
Reference: Author,
Journal, Year, PMID
Whole
sample
size
No. of
cases
No. of
controls
Age, yrs, mean
(SD), range
No.
(%) of
females
Quantitative Compositional
techniques
Semi-
quantitative
Cartilage Synovium Bone Bone
marrow
lesions
Meniscus Ligament Study
design
Downs
criteria
score
Karvonen RL; Journal
of Rheumatology;
1994; 796607513
92 52 40 All OA Pts: 55(14),
(Range: 25e86);
Bilateral
OA Pts: 53(13)
(Range: 25e73);
Control:
49(15), (Range: 22e78)
All OA Pts: 35;
Bilateral OA Pts:
19; Control: 25
X X X Case
control
11
Peterfy CG; Radiology;
1994; 802942014
8 5 3 62 (Range: 45e82) 4(50%) X X Cross-
sectional
4
Marshall KW; Journal of
Orthopaedic Research;
1995; 854401615
2 31 X X Other 6
Disler DG; AJR Am J
Roentgel.; 1996;
865935616
114 79 35 36 48 X X Cross-
sectional
6
Dupuy DE; Academic
Radiology; 1996;
895918117
7 2 5 TKA Pts:
(Range: 64e75);
Asymptomatic Pts:
(Range: 25e35)
TKA Pts: 1(50%);
Asymptomatic
Pts: 2
X X Other 6
Trattnig S; Journal
of Computer Assisted
Tomography;
1998; 944875418
20 20 0 72.2 (Range: 62e82) 18 X X Other 8
Drape JL; Radiology;
1998; 964679219
43 43 0 63 (Range: 53e78) 30 X X Cross-
sectional
5
Cicuttini F; Osteoarthritis &
Cartilage; 1999;
1032930120
28 Males: 41.4(14.8);
Females: 31.2(8.6)
11(39%) X X Cross-
sectional
7
Pham XV; Revue du
Rhumatisme; 1999;
1052638021
10 10 10 67.2(7.34),
(Range: 57e80)
6 X X Cross-
sectional
13
Gale DR; Osteoarthritis &
Cartilage; 1999;
1055885022
291 233 58 Men cases: 67(10);
Men controls 65(10);
Women cases: 66(10);
Women controls: 66(8)
61(21%) X Case
control
10
HyhlikeDurr A; European
Radiology; 2000;
1066376023
11 3 8 OA group: (Range:
61e75); Healthy group:
(Range: 25e36)
5(45.5%) X X Cross-
sectional
6
Jones G; Arthritis &
Rheumatism; 2000;
1108327924
92 0 92 Boys:12.8(2.7);
Girls: 12.6(2.9)
43(46.8%) X X X Cross-
sectional
13
Wluka AE; Annals of the
Rheumatic Diseases;
2001; 1124786125
81 42 39 Cases: 58(6.1);
Controls: 56(5.4)
81(100%) X X X Case
control
16
Felson DT; Annals of
Internal Medicine;
2001; 1128173626
401 401 0 66.8 X X Cross-
sectional
13
Hill CL; Journal of
Rheumatology;
2001; 1140912727
458 433 25 67 (34%) X X Case
control
13
Bergin D; Skeletal
Radiology; 2002;
1180758728
60 30 30 Cases: 50; Controls: 57 X X X Case
control
9
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Table I (continued )
Reference: Author,
Journal, Year, PMID
Whole
sample
size
No. of
cases
No. of
controls
Age, yrs, mean
(SD), range
No.
(%) of
females
Quantitative Compositional
techniques
Semi-
quantitative
Cartilage Synovium Bone Bone
marrow
lesions
Meniscus Ligament Study
design
Downs
criteria
score
Beuf O; Arthritis &
Rheumatism; 2002;
1184044129
46 18 28 Mild OA: 56.3(4.5);
Severe OA: 70(6.3)
17(37%) X Case
control
5
Wluka AE; Arthritis &
Rheumatism; 2002;
1220951030
123 123 0 63.1(10.6) 71 X X X Longitudinal
Prospective
14
Gandy SJ; Osteoarthritis &
Cartilage; 2002;
1246455331
16 16 0 6 X X Longitudinal
Prospective
8
Bhattacharyya T; Journal of
Bone & Joint Surgery -
American Volume;
2003; 1253356532
203 154 49 Cases: 65;
Controls: 67
X X Case
control
9
Cicuttini FM; Clinical &
Experimental
Rheumatology; 2003;
1267389333
81 42 39 ERT: 58(6.1);
Controls:
56(5.4)
81(100%) X X X Case
control
12
Raynauld JP; Osteoarthritis &
Cartilage; 2003;
1274494134
28 17 11 Healthy subjects:
(Range: 25e35);
OA Pts: 63.5
X X Other 7
Felson DT; Annals
of Internal Medicine;
2003; 1296594135
256 256 0 Followed:
66.2(9.4);
t followed:
67.8(9.6)
Followed:
41.7%; t
followed:
15.2%
X X Other 11
Hill CL; Arthritis &
Rheumatism; 2003;
1455808936
451 427 Knee pain/ROA/MALE:
68.3; Knee pain/ROA/
Female: 65; knee pain/
ROA/male: 66.8;
knee pain/ROA/
female:66.1
X X Cross-s
ectional
10
Glaser C; Magnetic Resonance
in Medicine; 2003;
1464857137
23 7 16 Healthy subjects:
(Range: 23e33);
OA Pts: 60e85
13(56.5%) X X Cross-
sectional
5
Lindsey CT; Osteoarthritis &
Cartilage; 2004; 1472386838
74 33 21 OA1(KL¼ 1/2):62.7(10.9);
OA2(KL¼ 3/4):66.6(11.6);
Controls: 34.2(12.5)
39(52.7%) X X X Case
control
8
Cicuttini FM; Arthritis &
Rheumatism; 2004;
1473060439
117 117 63.7(10.2) (58.1%) X X Longitudinal
Prospective
9
Raynauld JP; Arthritis &
Rheumatism; 2004;
1487249040
32 32 0 62.9(8.2) (74%) X X Longitudinal
Prospective
10
Cicuttini F; Rheumatology;
2004; 1496320141
117 117 0 67(10.6) (58.1%) X X Longitudinal
Prospective
12
Peterfy CG; Osteoarthritis &
Cartilage; 2004; 149723356
19 19 0 61(8) 4 X X X X X X X Other 5
Dashti M; Scandinavian
Journal of Rheumatology;
2004; 1516310942
174 117 57 61.6(9.5) 123(70.7%) X X Case control 11
Cicuttini FM; Journal of
Rheumatology; 2004;
1522995943
102 102 0 63.8(10.1) (63%) X X Longitudinal
Prospective
10
Baysal O; Swiss Medical
Weekly; 2004;
1524384944
65 65 0 53.1(7),
(Range: 45e75)
(100%) X X X X Cross-
sectional
7
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Kornaat PR; Skeletal
Radiology; 2005;
154806499
25 25 0 Median age¼ 63,
(Range: 50e75)
X X X X X X Other 6
Yoshioka H; Journal of
Magnetic Resonance
Imaging; 2004;
1550332345
28 28 0 55.6 (Range:
40e73)
10 X X X X X X Other 5
Ding C; Osteoarthritis &
Cartilage; 2005;
1572788546
372 162 210 cartilage defects:
43.6(7.1);
Any cartilage defects:
47(6.1)
(58%) X X X Case
control
9
Hill CL; Arthritis &
Rheumatism; 2005;
1575106447
433 360 73 Case males:68.2;
Case females:65;
Control males:66.8;
Control females:65.8
143(33%) X X Case
control
12
Maataoui A; European
Radiology; 2005;
1585624648
12 12 0 median age¼ 70.5,
(Range: 60e86)
9 X X Cross-
sectional
6
Cicuttini F; Osteoarthritis &
Cartilage; 2005;
1592263449
28 28 0 62.8(9.8) (57%) X X Longitudinal
Prospective
10
Huh YM; Korean Journal
of Radiology; 2005;
1596815150
94 73 21 OA group: 57.8,
(Range: 40e80),
Median¼ 58;
RA group:49.6,
(Range: 37e76),
Median¼ 48
73(80%) X X Longitudinal
Retropective
7
Wluka AE; Rheumatology;
2005; 1603008451
126 126 0 63.6(10.1) 68(54%) X X X X Longitudinal
Prospective
14
Eckstein, F; Annals of the
Rheumatic Diseases; 2006;
1612679752
19 10 9 51 (Range: 40e71) 12 X X X Other 8
Eckstein F; Arthritis &
Rheumatism; 2005;
1620059253
30 15 15 Cases: 49.6(Range:
37e76); Controls:
62.3(11.5)
30(100%) X X Cross-
sectional
7
Sengupta M; Osteoarthritis &
Cartilage; 2006; 1644231654
217 217 0 67.3(9.1) (30%) X X X X X Cross-
sectional
7
Raynauld JP; Arthritis Research &
Therapy; 2006; 1650711955
110 110 0 62.4(7.5) (64%) X X X X X Longitudinal
Prospective
11
Hunter DJ; Arthritis &
Rheumatism; 2006;
1650893056
257 257 0 66.6(9.2),
(Range: 47e93)
(41.6%) X X X Longitudinal
Prospective
10
Brandt KD; Rheumatology;
2006; 1660665557
30 20 10 62 29 X Other 10
Jaremko JL; Osteoarthritis &
Cartilage; 2006; 1664424558
12 3 9 OA: (Range:
59e71); )
Healthy: 37(8),
(Range: 23e48)
4(33.3%) X X Cross-
sectional
8
Hunter DJ; Osteoarthritis &
Cartilage; 2007; 1685739359
127 127 67(9.05) (46.7%) X X Cross-
sectional
12
Boks SS; American Journal
of Sports Medicine; 2006;
1686157560
134 136 132 40.8 (Range:
18.8e63.8)
X X X X Cross-
sectional
7
Brem MH; Skeletal Radiology;
2007; 1721923161
5 5 0 64.3 (Range:
40e73)
2 X X Other 6
Folkesson J; IEEE
Transactions on Medical
Imaging; 2007; 1724358962
139 56 (Range: 22e79) (59%) X X Other 7
(continued on next page)
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Table I (continued )
Reference: Author,
Journal, Year, PMID
Whole
sample
size
No. of
cases
No. of
controls
Age, yrs, mean
(SD), range
No.
(%) of
females
Quantitative Compositional
techniques
Semi-
quantitative
Cartilage Synovium Bone Bone
marrow
lesions
Meniscus Ligament Study
design
Downs
criteria
score
Dam EB; Osteoarthritis &
Cartilage; 2007;
1735313263
139 Evaluation set:
55(Range:
21e78);
Scan-rescan set:
51,(Range: 26e75)
(55%) X X Other 9
Baranyay FJ; Seminars in
Arthritis & Rheumatism;
2007; 1739173864
297 297 58(5.5) (63%) X X X Cross-
sectional
16
Hanna F; Mepause;
2007; 1741364965
176 0 176 52.3(6.6),
(Range: 40e67)
176(100%) X X Cross-
sectional
13
Hunter DJ; Annals of the
Rheumatic Diseases;
2008; 174729958
71 67.9(9.3) (28.2%) X X X X X X X Other 8
Hill CL; Annals of the Rheumatic
Diseases; 2007; 1749109666
270 270 0 66.7(9.2) 112 X X X Longitudinal
Prospective
9
Qazi AA; Osteoarthritis &
Cartilage; 2007; 1749384167
X X Cross-
sectional
8
Guymer E; Osteoarthritis &
Cartilage; 2007; 1756013468
176 0 176 52.3(6.6) (100%) X X X X Cross-
sectional
11
Eckstein F; Osteoarthritis &
Cartilage; 2007; 1756081369
9 9 52.2(9.3) 5 X X Other 9
Akhtar, S; Osteoarthritis &
Cartilage; 2007; 1770766070
6 (Range: 25e69) 2(33%) X X Other 7
Raynauld JP; Annals of the
Rheumatic Diseases; 2008;
1772833371
107 107 0 62.4(7.5) (64%) X X X X Longitudinal
Retropective
15
Felson DT; Arthritis &
Rheumatism; 2007;
1776342772
330 110 220 Cases: 62.9(8.3);
Controls: 61.2(8.4)
211(64%) X X X Case control 12
Lo GH; Osteoarthritis &
Cartilage; 2008;
1782558673
845 170 63.6(8.8) (58%) X X Cross-
sectional
10
Davies-Tuck M; Osteoarthritis &
Cartilage; 2008; 1786954674
100 100 0 63.6(10.2) 61(61%) X X Longitudinal
Prospective
11
Folkesson J; Academic Radiology;
2007; 1788933975
. 56 (Range: 22e79) (59%) Other 7
Sanz R; Journal of Magnetic
Resonance Imaging;
2008; 1802285076
22 9 Normal: 43.6(15);
Chondromalacia:
33.3(11.8); OA Pts:
58.9(11.5)
14(64%) X X Case control 6
Englund M; Arthritis &
Rheumatism; 2007;
1805020177
310 102 208 Cases: 62.9(8.3);
Controls: 61.2(8.3)
211(68%) X X Case control 15
Hernandez-Molina G;
Arthritis & Rheumatism;
2008; 1816348378
258 258 0 66.6(9.2) (42.6%) X X X X Longitudinal
Prospective
11
Amin S; Osteoarthritis &
Cartilage; 2008;
1820362979
265 265 67(9) (43%) X X X X Longitudinal
Prospective
11
Teichtahl AJ; Obesity;
2008; 1823965480
297 297 58(5.5) 186 X X X X Longitudinal
Prospective
14
Anandacoomarasamy;
Journal of Rheumatology;
2008; 1827883181
32 32 Males: 64(11.5);
Females: 66(9.5);
Total: 65(Range:
42e87)
17(53%) X X X Longitudinal
Prospective
11
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Eckstein F; Annals of the
Rheumatic Diseases;
2008; 1828305482
158 Mild to moderate
OA2: 57.6(8.3);
Controls: 56.1(8.7)
158(100%) X X Case control 10
Reichenbach S;
Osteoarthritis &
Cartilage; 2008;
1836741583
964 217 747 63.3 (57%) X X X Cross-
sectional
8
Petterson SC; Medicine &
Science in Sports &
Exercise; 2008;
1837920284
123 123 0 64.9(8.5) 67 Case
control
11
Bolbos RI;
Osteoarthritis &
Cartilage; 2008;
1838782885
32 Cases: 47.2(11.5),
(Range: 29e72);
Controls: 36.3(10.5),
Range: (27e56)
14(44%) X X X X Case
control
7
Pai A; Magnetic
Resonance Imaging;
2008; 1850207386
10 0 10 27 (Range: 21e31) 4(40%) X X Other 6
Folkesson J; Magnetic
Resonance in Medicine;
2008; 1850684587
143 Healthy subjects:
48(Range: 21e78);
KL1: 62(Range: 37e81);
KL2: 67(Range: 47e78);
KL3&4: 68(58e78)
X Other 12
Mills PM; Osteoarthritis &
Cartilage; 2008;
1851515788
49 25 24 APMM: 46.8(5.3);
Controls: 43.6(6.6)
18(36.7%) X X X Case
control
12
Dore D; Osteoarthritis &
Cartilage; 2008;
1851516089
50 50 64.5(7.1) 23 X X X X Cross-
sectional
9
Pelletier JP;
Osteoarthritis &
Cartilage; 2008;
1867238690
27 1 64.1(9.6) 14 X X X X X X Other 9
Englund M; New England
Journal of Medicine;
2008; 1878410091
991 171 62.3(8.6),
(Range: 50.1e90.5)
565(57%) X X Cross-
sectional
10
Rauscher I; Radiology;
2008; 1893631592
60 37 23 Healthy controls:
34.1(10); Mild OA:
52.5(10.9); Severe OA:
61.6(11.6)
32(53.3%) X X X Case
control
9
Kijowski R.; Radiology;
2009; 1916412193
200 200 1.5T image group:
38.9(Range: 16e63);
3T image group:
39.1(Range: 15e65)
87(43.5%) X X Longitudinal
Retropective
10
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Table III
Results of random-effects pooling of inter-reader CV from MRI studies stratiﬁed by
measure (quantitative and semi-quantitative) and tissue (cartilage, synovium, bone,
bone marrow lesion, meniscus, and ligament)
Stratiﬁcation Number of
estimates
(Studies)
Mean sample
size
Pooled CV (%) 95% CI
Quantitative
Cartilage 42 (13) 65 3 1, 6
Synovium 1 (1) 94 5 15, 25
Bone 9 (5) 119 2 4, 8
Table IV
Results of random-effects pooling of intra-reader ICC from MRI studies stratiﬁed by
measure (quantitative and semi-quantitative) and tissue (cartilage, synovium, bone,
bone marrow lesion, meniscus, and ligament)
Stratiﬁcation Number of Mean Pooled ICC 95% CI
D.J. Hunter et al. / Osteoarthritis and Cartilage 19 (2011) 589e605596In contrast to quantitative measures semi-quantitative image
analysis is typically much more observer dependent and generates
grades or scales rather than truly continuous output. Semi-quan-
titative scoring of MRI’s are a valuable method for performing
multi-feature assessment of the knee using conventional MRI
acquisitions6e8,98. Such approaches score, in an observer depen-
dent semi-quantitative manner, a variety of features that are
currently believed to be relevant to the functional integrity of the
knee and/or potentially involved in the pathophysiology of OA.
These articular features can include articular cartilage morphology,
subarticular bone marrow abnormality, subarticular cysts, sub-
articular bone attrition, marginal and central osteophytes, medial
and lateral meniscal integrity, anterior and posterior cruciate liga-
ment integrity, medial and lateral collateral ligament integrity,
synovitis/effusion, intra-articular loose bodies, and periarticular
cysts/bursitis.
The Downs methodological quality score3 collects a proﬁle of
scores (quality of reporting, internal validity (bias and confounding),
power, external validity so that the overall study quality score
reﬂects all of these elements. Answers were scored 0 (No) or 1 (Yes),
except for one item in the Reporting subscale, which scored 0e2 and
the single item on power, which was scored 0e5. The possible range
is from0e27where 0 represents poor quality and 27 optimal quality.
The outcomes for psychometric properties on MRI were exam-
ined using the OMERACT ﬁlter10,11. The material pertinent to this
manuscript is Discrimination: does the measure discriminate
between situations that are of interest? The situations can be states
at one time (for classiﬁcation or prognosis) or states at different
times (to measure change). This criterion captures the issues of
reliability and responsiveness (sensitivity to change).
Statistical analysis
Reliability was deﬁned by inter- and intra-reader measures of
coefﬁcient of variation (CV), or intra-class correlation (ICC), or
kappa statistics.
Responsiveness was deﬁned as standardized response mean
(SRM) - ratio of mean of change over time divided by standard
deviation of change. Whenever possible, both reliability measures
and SRMs were stratiﬁed by measurement method (quantitative
and semi-quantitative), tissue lesion (cartilage, synovium, bone,
bone marrow lesions, meniscus and ligament) and plate/region for
cartilage divisions.
For the quantitative analysis, a negative SRM expresses cartilage
loss whereas a positive SRM would indicate cartilage gain. For the
semi-quantitative analysis, positive SRMs indicate a loss in cartilage
with higher scores reﬂecting greater lesions.
Random-effects models were used to summarize data from
multiple studies. Since some studies reported more than one
measure for each region, to avoid substantial skewness of results
inﬂuenced by multiple observations from a single study and to
ensure that the estimates included in the analysis came from
independent studies, we repeated analyses 500 times. We did this
by selecting one observation (estimate) from each study at randomTable II
Results of random-effects pooling of intra-reader CV from MRI studies stratiﬁed by
measure (quantitative and semi-quantitative) and tissue (cartilage, synovium, bone,
bone marrow lesion, meniscus, and ligament)
Stratiﬁcation Number of estimates
(Studies)
Mean sample
size
Pooled CV (%) 95% CI
Quantitative
Cartilage 32 (10) 60 3 2, 7
Synovium 2 (1) 94 8 6, 22
Compositional 6 (1) 60 5 5, 15so that the number of observations in the model reﬂected the
number of studies. We then ran a random-effects model to obtain
the pooled summary measure and its standard error. The process
was repeated 500 times to obtain the empirical distribution of the
summary measure. The ﬁnal pooled summary measure and its
standard error were obtained by averaging the 500 summary
measures and the 500 standard errors obtained from the random-
effects models respectively. Ninety-ﬁve percent conﬁdence inter-
vals (CI) were obtained using a normal approximation for the ﬁnal
pooled summary measure and its standard error.
Results
Reliability
The reliability analysis included data from 84 manuscripts
(Table I). The mean Downs criteria score for these manuscripts was
9.4 (range 4e16).
Inter- and intra-reader CV and test-retest measures were
conﬁned to quantitative or compositional measures (Tables II and
III). The pooled CV for quantitative cartilage was 3% for both
inter- and intra-reader reliability.
The inter-reader and intra-reader ICCs for quantitative and
semi-quantitative measures were all excellent (range
0.8e0.94)(Tables IV and V). For quantitative measures the intra-
reader ICC ranged from 0.87 (0.61e1.00) for synovium to 0.93
(0.82e1.00) for meniscus measurement. For quantitative measures
the inter-reader ICC ranged from 0.81 (0.72e0.89) for meniscus to
0.90 (0.86e0.95) for cartilage morphometry measurement.
The inter-reader and intra-reader kappa values for quantitative
and semi-quantitative measures were all moderate to excellent
(range 0.52e0.88)(Tables VI and VII). For semi-quantitative
measures the range for intra-reader kappa values extended from
0.52 (0.28e0.77) for synovium to 0.66 (0.54e0.78) for BML
assessment. For semi-quantitative measures the range for inter-
reader kappa values extended from 0.57 (0.44e0.71) for cartilage
morphology to 0.88 (0.79e0.97) for BML assessment.estimates
(Studies)
sample
size
Quantitative
Cartilage 23 (9) 108 0.92 0.88, 0.96
Synovium 2 (1) 30 0.87 0.61, 1.00
Meniscus 1 (1) 291 0.93 0.82, 1.00
Semi-quantitative
Cartilage 7 (4) 114 0.94 0.87, 1.00
Synovium 3 (2) 26 0.88 0.66, 1.00
Bone Marrow Lesion 2 (2) 178 0.93 0.83, 1.00
Meniscus 2 (1) 25 0.77 0.49, 1.00
Table V
Results of random-effects pooling of inter-reader ICC from MRI studies stratiﬁed by
measure (quantitative and semi-quantitative) and tissue (cartilage, synovium, bone,
bone marrow lesion, meniscus, and ligament)
Stratiﬁcation Number of
estimates
(Studies)
Mean
sample
size
Pooled ICC 95% CI
Quantitative
Cartilage 10 (4) 196 0.90 0.86, 0.95
Meniscus 2 (1) 291 0.81 0.72, 0.89
Semi-Quantitative
Cartilage 9 (7) 88 0.85 0.77, 0.94
Synovium 5 (4) 46 0.87 0.74, 1.00
Bone 3 (2) 23 0.90 0.66, 1.00
Bone Marrow Lesion 2 (2) 22 0.84 0.54, 1.00
Meniscus 5 (3) 67 0.93 0.82, 1.00
Ligament 4 (2) 105 0.80 0.56, 1.00
Table VII
Results of random-effects pooling of inter-reader kappa values from MRI studies
stratiﬁed by measure (quantitative and semi-quantitative) and tissue (cartilage,
synovium, bone, bone marrow lesion, meniscus, and ligament)
Stratiﬁcation Number of
estimates
(Studies)
Mean
sample
size
Pooled Kappa 95% CI
Semi-quantitative
Cartilage 15 (4) 136 0.57 0.44, 0.71
Bone marrow lesion 2 (2) 237 0.88 0.79, 0.97
Meniscus 3 (3) 418 0.73 0.63, 0.84
Ligament 3 (3) 209 0.80 0.69, 0.90
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The responsiveness analysis included data from 42 manuscripts
(Table VIII). The mean Downs criteria score for these manuscripts
was 11.2 (range 8e21). Table IX includes the summary respon-
siveness data for both types of measurementmethods (quantitative
and semi-quantitative). As some studies reported multiple esti-
mates, random-effects model pooling was done to reduce potential
bias from studies reporting multiple estimates. The pooled SRM for
quantitative measures of cartilage morphometry for the medial
tibiofemoral joint was 0.86 (95%CI 1.26 to 0.46), for lateral
tibofemoral joint was 1.01 (95%CI 2.04 to 0.02), and for the
patella was 0.63 (95%CI 0.90 to 0.37). The quantitative carti-
lage morphometry pooled SRM ranged from 0.21 (0.48 to 0.05)
for the lateral femoral plate to 1.01 (2.04 to 0.02) for lateral
tibiofemoral plate. The results for the compositional measures are
from one study and should be interpreted with caution. The pooled
SRM for semi-quantitative measures of cartilage for medial tibio-
femoral joint was 0.55 (95%CI 0.47e0.64), for lateral tibofemoral
joint was 0.37 (95%CI 0.18e0.57), and for the patella was 0.29 (95%
CI 0.03e0.56). The semi-quantitative cartilage morphology SRMs
ranged from 0.07 (0.18 to 0.04) for the medial tibial region to
0.55 (0.47e0.64 for themedial tibiofemoral region. The pooled SRM
for semi-quantitative measures of synovium was 0.47 (95%CI
0.18e0.77), and for BMLs was 0.43 (95%CI 0.17 to 1.03).
There has been some concern that some of the earlier literature
for quantitative measures of cartilage morphometry was more
responsive than more recent estimates. Table X reﬂects an effort to
distil distinct time periods. In general, the earlier estimates
demonstrate larger SRMs than more recent studies with the medial
tibiofemoral estimates from 2002e2006 being 0.95 (1.15,
0.76) and from more recent studies (2007e2009) being 0.84
(1.35, 0.33).
Table XI shows the results of random-effects pooling of SRM
from MRI studies evaluating quantitative cartilage stratiﬁed byTable VI
Results of random-effects pooling of intra-reader kappa values from MRI studies
stratiﬁed by measure (quantitative and semi-quantitative) and tissue (cartilage,
synovium, bone, bone marrow lesion, meniscus, and ligament)
Stratiﬁcation Number of
estimates
(Studies)
Mean
sample
size
Pooled Kappa 95% CI
Quantitative
Cartilage 1 (1) 158 0.66 0.50, 0.82
Semi-Quantitative
Synovium 4 (2) 317 0.52 0.28, 0.77
Bone Marrow Lesion 1 (1) 256 0.66 0.54, 0.78duration of study and plate region for studies published between
2007 and 2009. Studies with multiple estimates had an estimate
selected at random and a pooled analysis was performed. In this
analysis the pooled SRM for the medial tibiofemoral joint for
studies of 1 year or less is 0.80 (1.27, 0.33) and for studies of
1e2 years is 1.16 (2.90, 0.58).
Discussion
The purpose of this studywas to summarize the literature on the
responsiveness and reliability of MRI-based measures of knee OA
structural change. In general, this review provides clear evidence
that structural change in OA can be measured both reliably and
with good responsiveness on MRI.
The data from this review indicates that quantitative measures
of joint structure have excellent reliability (ICC range 0.81e0.94).
Similarly agreement for semi-quantitative measures is good to
excellent (kappa range 0.52e0.88). Directly comparing the reli-
ability between quantitative and semi-quantitative techniques is
not possible given the extracted data comes from different studies
and the statistical methods used are frequently distinct but an
overarching view would suggest they are broadly comparable with
a slight beneﬁt in reliability for quantitative measures. This is not
surprising given the continuous nature of these measures, the
greater use of technology to automate processes and quality control
vigilance in quantitative measures.
The aim of the systematic review is to provide a summary of
the best evidence. However, as a result of issues related to the
quality of research, ﬁndings of studies can sometimes be
misleading or incorrect. To minimize these risks, the quality of the
studies was critically appraised using Downs checklist3. The
ﬁndings from our review indicate that in general this literature is
of adequate quality. No studies were identiﬁed in our search prior
to 1994.
Several studies have suggested that baseline clinical,
biomarker and imaging features are predictive of progression of
cartilage loss in the medial compartment of the knee and could be
used to provide greater study power by selecting a population at
greater risk for more rapid progression. Whilst the estimates
included in this analysis reﬂect these studies we have not
explicitly selected for these studies so the pooled estimates reﬂect
all studies not just selected estimates for those at highest risk for
progression.
This review does not include results focused upon using MRI to
stage OA. Whilst MRI has been extensively used for measuring
progression its use in staging OA as a disease is at this point quite
limited. In an effort to shorten discovery and development time-
lines, clinical trial brevity is paramount. As OA is typically a very
slowly progressive condition, one can optimize trial efﬁciency by
ﬁnding more responsive endpoint/s. The results of the respon-
siveness data reafﬁrm the potential beneﬁt of MRI compared to
plain radiography that generally has SRMs in the 0.3e0.4 range12.
Table VIII
Summary table of studies reporting data on responsiveness of MRI in OA
Reference: Author,
Journal, Year, PMID
Whole
sample
size
No. of
cases
No. of
controls
Age, yrs, Mean(SD),
Range
No.
(%) of
females
Quantitative Compositional
technique
Semi-
quantitative
Cartilage Synovium Bone Bone
marrow
lesions
Meniscus Ligament Study
design
Downs
criteria
score
Wluka AE; Arthritis &
Rheumatism; 2002;
1220951030
123 123 0 63.1(10.6) 71 X X X Longitudinal
Prospective
14
Cicuttini FM; Journal of
Rheumatology; 2002;
1223389294
21 8 13 Case:41.
3(13.2);
Controls:
49.2(17.8)
14(66.7%) X X Longitudinal
Prospective
13
Biswal S; Arthritis &
Rheumatism; 2002;
124282287
43 4 39 54.4(Range
17e65)
21 X X Longitudinal
Prospective
8
Gandy SJ; Osteoarthritis &
Cartilage; 2002; 1246455331
16 16 0 63.4 (Range
52e70)
6 X X Longitudinal
Prospective
8
Wluka AE; Journal of
Rheumatology; 2002;
1246515795
136 136 0 Vitamin E group:
64.3(11);
Placebo group:
63.7(10)
75(55%) X X Randomized
controlled
trial
21
Cicuttini F; Journal of
Rheumatology; 2002;
1246516296
110 110 0 63.2(10.2) 66 X X Longitudinal
Prospective
12
Pessis E; Osteoarthritis &
Cartilage; 2003; 1274494297
20 20 63.9(9) 13 X X X Longitudinal
Prospective
12
Cicuttini FM; Arthritis &
Rheumatism; 2004;
1473060439
117 117 63.7(10.2) (58.1%) X X Longitudinal
Prospective
9
Raynauld JP; Arthritis &
Rheumatism; 2004;
1487249040
32 32 0 62.9(8.2) (74%) X X Longitudinal
Prospective
10
Wluka AE; Annals of the
Rheumatic Diseases;
2004; 1496296098
132 132 0 63.1(Range:
41e86)
71(54%) X X Longitudinal
Prospective
10
Cicuttini FM; Journal of
Rheumatology; 2004;
1522995943
102 102 0 63.8(10.1) (63%) X X Longitudinal
Prospective
10
Blumenkrantz G; Osteoarthritis &
Cartilage; 2004; 1556406799
38 30 8 58(Range:
28e81)
(39.5%) X X X Longitudinal
Prospective
9
Zhai G; BMC Musculoskeletal
Disorders; 2005; 15720725100
150 80 70 TASOAC dataset:
62.3(7.6);
KCV dataset:
42.8(6.1)
79(52.7%) X X Other 9
Wang Y; Arthritis Res
Ther; 2005; 15899054101
126 126 63.6(10.1) 68 X Longitudinal
Prospective
12
Cicuttini F; Osteoarthritis &
Cartilage; 2005; 1592263449
28 28 0 62.8(9.8) (57%) X X Longitudinal
Prospective
10
Wluka AE; Rheumatology;
2005; 1603008451
126 126 0 63.6(10.1) 68(54%) X X Longitudinal
Prospective
14
Ding C; Arthritis &
Rheumatism; 2005;
16320339102
325 45.2(6.5) 190 X X X Longitudinal
Prospective
10
Raynauld JP; Arthritis
Research & Therapy;
2006; 1650711955
110 110 0 62.4(7.5) (64%) X X Longitudinal
Prospective
11
Hunter DJ; Arthritis &
Rheumatism; 2006;
1650893056
257 257 0 66.6(Range:
47e93)
(41.6%) X X Longitudinal
Prospective
10
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Hunter, DJ; Osteoarthritis &
Cartilage; 2006; 16678452103
150 150 0 58.9(Range:
44e81)
(72%) X X X X X X Longitudinal
Prospective
9
Wluka AE; Arthritis Research &
Therapy; 2006; 16704746104
105 105 0 All eligible:
62.5(10.7);
MRI at FU:
63.8(10.6);
Lost to FU:
61.6(11.3)
61(58.1%) X X Longitudinal
Prospective
17
Ding C; Rheumatology; 2007;
16861710105
325 45.2(6.4) 190 X X Longitudinal
Prospective
12
Hunter DJ; Arthritis &
Rheumatism; 2006;
16868968106
264 264 0 66.7(9.2),
(Range:
47e93)
(40.9%) X X X Longitudinal
Prospective
9
Bruyere O; Osteoarthritis
Cartilage; 2007;
16890461107
62 64.9 (10.3) (74%) X X Longitudinal
Prospective
10
Stahl R; Osteoarthritis &
Cartilage; 2007;
17561417108
18 8 10 OA Pts:
55.7(7.3);
Controls:
57.6(6.2)
18(100%) X X Case control 10
Pelletier JP; Arthritis
Research & Therapy;
2007; 17672891109
110 110 Q1greatestlossglobal:
63.7(7.2);
Q4 least loss
global: 61.3(7.5); Q1
greatest loss_med:
64.1(7.4); Q1 least
loss_medial: 61.6(7.8)
74(67.3%) X X Longitudinal
Prospective
15
Raynauld JP; Annals of the
Rheumatic Diseases;
2008; 1772833371
107 107 0 62.4(7.5) (64%) X X X Longitudinal
Retrospective
15
Davies-Tuck M; Osteoarthritis &
Cartilage; 2008; 1786954674
100 100 0 63.3(10.2) 61(61%) X X Longitudinal
Prospective
11
Hunter DJ; Arthritis Research &
Therapy; 2007; 17958892110
160 80 80 67(9) (46%) X X Case control 11
Teichtahl AJ; Osteoarthritis &
Cartilage; 2008; 18194873111
99 99 0 63(10) (60%) X X Longitudinal
Prospective
14
Hunter DJ; Annals of the
Rheumatic Diseases; 2009;
18408248112
150 150 60.9(9.9) 76(51%) X X Longitudinal
Prospective
8
Folkesson J; Magnetic Resonance
in Medicine; 2008; 1850684587
288 143 KL0(Healthy):
48(Range:
21e78); KL1:
62(Range:
37e81); KL2:
67(Range: 47e78);
KL3&4: 68(Range:
58e78)
(44%) X Other 12
Sharma L; Arthritis &
Rheumatism;
2008; 18512777113
153 153 0 66.4(11) X X Longitudinal
Prospective
11
Teichtahl AJ; Osteoarthritis &
Cartilage; 2009; 18590972114
78 63 (10.5) (52%) X X Longitudinal
Prospective
14
Raynauld JP; Annals Rheumatic
Disease; 2009; 18653484115
154 60.3 (8.1) 100 (65%) X X Randomized
controlled
trial
11
Pelletier JP; Osteoarthritis &
Cartilage; 2008; 1867238690
27 1 64.1(9.6) 14 X X X X X Other 9
Wirth W; Osteoarthritis &
Cartilage; 2009; 18789729116
79 60.3 (9.5) 79 (100%) X X Longitudinal
Prospective
14
(continued on next page)
D
.J.H
unter
et
al./
O
steoarthritis
and
Cartilage
19
(2011)
589
e
605
599
Ta
b
le
V
II
I
(c
on
ti
nu
ed
)
R
ef
er
en
ce
:
A
u
th
or
,
Jo
u
rn
al
,Y
ea
r,
PM
ID
W
h
ol
e
sa
m
p
le
si
ze
N
o.
of
ca
se
s
N
o.
of
co
n
tr
ol
s
A
ge
,y
rs
,M
ea
n
(S
D
),
R
an
ge
N
o.
(%
)
of
fe
m
al
es
Q
u
an
ti
ta
ti
ve
C
om
p
os
it
io
n
al
te
ch
n
iq
u
e
Se
m
i-
qu
an
ti
ta
ti
ve
C
ar
ti
la
ge
Sy
n
ov
iu
m
B
on
e
B
on
e
m
ar
ro
w
le
si
on
s
M
en
is
cu
s
Li
ga
m
en
t
St
u
d
y
d
es
ig
n
D
ow
n
s
cr
it
er
ia
sc
or
e
Ec
ks
te
in
F;
A
rt
h
ri
ti
s
&
R
h
eu
m
at
is
m
;
20
08
;
18
97
53
56
1
1
7
17
4
17
4
0
66
(1
1.
1)
(7
6%
)
X
X
Lo
n
gi
tu
d
in
al
Pr
os
p
ec
ti
ve
8
H
el
lio
Le
G
ra
ve
ra
n
d
M
P;
A
n
n
al
s
R
h
eu
m
at
ic
D
is
ea
se
s;
20
08
;
19
10
36
34
1
1
8
18
0
(1
00
%
)
X
X
Lo
n
gi
tu
d
in
al
Pr
os
p
ec
ti
ve
19
Ec
ks
te
in
F;
A
rt
h
ri
ti
s
R
es
ea
rc
h
Th
er
ap
y;
20
09
;
19
53
47
83
1
1
9
79
60
.3
(9
.5
)
79
(1
00
%
)
X
X
Lo
n
gi
tu
d
in
al
Pr
os
p
ec
ti
ve
15
Ec
ks
te
in
F;
A
rt
h
ri
ti
s
R
h
eu
m
;
20
09
:
19
71
45
95
1
2
0
80
60
.9
(9
.1
)
48
(6
0%
)
X
X
Lo
n
gi
tu
d
in
al
Pr
os
p
ec
ti
ve
14
H
u
n
te
r
D
J;
O
st
eo
ar
th
ri
ti
s
&
C
ar
ti
la
ge
;
20
09
;
19
74
45
88
1
2
1
15
0
15
0
60
.9
(9
.9
)
76
(5
1%
)
X
X
Lo
n
gi
tu
d
in
al
Pr
os
p
ec
ti
ve
18
Table IX
Results of random-effects pooling of SRM from MRI studies stratiﬁed by measure
(quantitative and semi-quantitative) and tissue (cartilage, synovium, bone, bone
marrow lesion, meniscus, and ligament). Studies with multiple estimates had an
estimate selected at random and a pooled analysis was performed. The process was
repeated 500 times to obtain the empirical distribution of pooled SRMs
Stratiﬁcation Number of
estimates
(Studies)
Mean
sample
size
Pooled
SRM
95% CI
Quantitative cartilage*
Medial femoral 54 (12) 118 0.51 0.74, 0.28
Medial tibial 55 (17) 134 0.48 0.63, 0.34
Medial tibiofemoral 31 (12) 92 0.86 1.26, 0.46
Lateral femoral 32 (8) 151 0.21 0.48, 0.05
Lateral tibial 44 (14) 152 0.56 0.72, 0.39
Lateral tibiofemoral 14 (5) 110 1.01 2.04, 0.02
Patella 13 (9) 131 0.63 0.90, 0.37
Global 5 (4) 48 0.89 2.59, 0.80
Quantitative other*
Denuded area 19 (2) 114 0.20 0.85, 0.45
Bone 14 (2) 167 0.12 0.46, 0.70
Bone marrow lesion 4 (1) 107 0.11 0.08, 0.30
Meniscus 2 (1) 264 0.24 0.36, 0.12
Compositional 3 (1) 18 3.27 3.73, 2.81
Semi-quantitative cartilagey
Medial tibial 1 (1) 325 0.07 0.18, 0.04
Medial tibiofemoral 3 (3) 224 0.55 0.47, 0.64
Lateral tibial 1 (1) 325 0.05 0.15, 0.06
Lateral tibiofemoral 3 (3) 224 0.37 0.18, 0.57
Patella 2 (2) 238 0.29 0.03, 0.56
Semi-quantitative other*
Synovium 3 (2) 68 0.47 0.18, 0.77
Osteophytes 4 (1) 150 0.36 0.20, 0.52
Bone marrow lesion 6 (2) 130 0.43 0.17, 1.03
Meniscus 2 (1) 264 0.27 0.15, 0.39
* Analysis used re-sampling techniques.
y Analysis did not use re-sampling techniques.
D.J. Hunter et al. / Osteoarthritis and Cartilage 19 (2011) 589e605600For MRI there is quite a lot of variability between different regions
within the knee, and with different measures of different tissues,
yet the SRM of0.86 (95%CI 1.26 to 0.46) for the medial tibio-
femoral joint quantitative cartilage measure provides advantages
with regards to adequately powering studies.
Interestingly there have been a number of concerns raised
about what appears to be conﬂicting data from earlier studies
that were more responsive than studies conducted more
recently. This analysis conﬁrms that more recent studies
(2007e2009) have slightly more conservative SRMs than earlier
studies (2002e2006). For example the SRM for the medial
tibiofemoral joint quantitative cartilage measure is 0.95 (1.15,
0.76) for studies from 2002e2006 and is 0.84 (1.35, 0.33)
for studies from 2007 to 2009. The CIs for both these periods
overlap and while there may be some differences in techniques
between the two time periods including routine blinding to
sequence in more recent studies that may explain differences,
identifying the reasons for these differences was not the focus of
this analysis. We have also been able to clearly demonstrate that
adequate responsiveness can be attained in periods as short as 12
months.
Semi-quantitative scoring of MRIs is a valuable method for
performing multi-feature assessment of the knee using conven-
tional MRI acquisitions6e8,98. The responsiveness of the semi-
quantitative assessment of medial tibiofemoral cartilage
morphology (SRM 0.55) is broadly consistent with quantitative
assessment for the medial tibiofemoral joint. Semi-quantitative
assessment of synovium also demonstrated good responsiveness
(SRM 0.52). In addition the semi-quantitative assessment of BMLs,
a structural target with good clinical and predictive validity was
also adequately responsive (SRM 0.43).
Table X
Results of random-effects pooling of SRM from MRI studies evaluating quantitative
cartilage stratiﬁed by year of publication and plate region. Studies with multiple
estimates had an estimate selected at random and a pooled analysis was performed.
The process was repeated 500 times to obtain the empirical distribution of pooled
SRMs
Stratiﬁcation Number of
estimates
(Studies)
Mean
sample
size
Pooled SRM 95% CI
2002e2006
Medial femoral 3 (3) 126 0.59 1.21, 0.03
Medial tibial 7 (7) 123 0.58 0.81, 0.35
Medial tibiofemoral* 4 (3) 51 0.95 1.15, 0.76
Lateral femoral 1 (1) 117 0.01 0.19, 0.17
Lateral tibial 6 (6) 139 0.55 0.82, 0.29
Patella 5 (5) 141 0.68 1.04, 0.32
Global 2 (2) 24 0.58 1.15, 0.02
2007e2009
Medial femoral 51 (9) 117 0.49 0.75, 0.22
Medial tibial 48 (10) 135 0.42 0.62, 0.22
Medial tibiofemoral 27 (9) 98 0.84 1.35, 0.33
Lateral femoral 31 (7) 152 0.24 0.53, 0.05
Lateral tibial 38 (8) 154 0.56 0.79, 0.33
Lateral tibiofemoral 14 (5) 110 1.01 2.04, 0.02
Patella 8 (4) 125 0.58 0.97, 0.18
Global 3 (2) 63 1.24 4.42, 1.94
* Note: All analyses of articles published in 2002e2006 did not use re-sampling
techniques except for the medial tibial-femoral component. All analyses of articles
published in 2007e2009 did use re-sampling techniques.
D.J. Hunter et al. / Osteoarthritis and Cartilage 19 (2011) 589e605 601In summary, OA changes on MRI can be measured reliably using
both quantitative and semi-quantitative techniques. MRI can
accurately and feasibly measure change in quantitative cartilage
morphometry over 12 months for knee OA. Based upon extant
literature these study ﬁndings strongly support inclusion of MRITable XI
Results of random-effects pooling of SRM from MRI studies evaluating quantitative
cartilage stratiﬁed by duration of study and plate region for studies published
between 2007 and 2009. Studies withmultiple estimates had an estimate selected at
random and a pooled analysis was performed. The process was repeated 500 times
to obtain the empirical distribution of pooled SRMs
Stratiﬁcation Number of
estimates
(Studies)
Mean
sample
size
Pooled SRM 95% CI
Quantitative cartilage
1 year or less
Medial femoral 27 (5) 82 0.49 0.81, 0.17
Medial tibial 18 (6) 93 0.33 0.53, 0.13
Medial tibiofemoral 16 (6) 83 0.80 1.27, 0.33
Lateral femoral 7 (3) 137 0.30 0.98, 0.38
Lateral tibial 8 (4) 130 0.56 0.88, 0.24
Lateral tibiofemoral 3 (2) 79 1.03 2.79, 0.73
Patella 7 (3) 129 0.47 0.92, 0.02
Global 2 (1) 18 0.45 0.01, 0.92
1e2 years
Medial femoral 6 (3) 104 0.51 1.15, 0.13
Medial tibial 6 (3) 104 0.63 1.14, 0.12
Medial tibiofemoral 5 (2) 53 1.16 2.90, 0.58
Lateral femoral 6 (3) 104 0.21 0.51, 0.09
Lateral tibial 6 (3) 104 0.61 1.14, 0.08
Lateral tibiofemoral 5 (2) 53 1.28 3.48, 0.91
Patella 1 (1) 99 0.90 1.10, 0.71
Global 1 (1) 154 2.85 3.01, 2.70
Greater than 2 years*
Medial femoral 18 (1) 174 0.32 0.47, 0.17
Medial tibial 24 (1) 174 0.27 0.42, 0.12
Medial tibiofemoral 6 (1) 174 0.41 0.56, 0.26
Lateral femoral 18 (1) 174 0.22 0.37, 0.07
Lateral tibial 24 (1) 174 0.42 0.57, 0.27
Lateral tibiofemoral 6 (1) 174 0.43 0.57, 0.28
* Represents results of one study117.structure in updated regulatory guidance statements for clinical
trials of structure modifying agents in OA.
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